Hisataka Moriwaki Selected Research

Hisataka Moriwaki Research Topics

Disease

80	Neoplasms (Cancer) 01/2018 - 09/2002
56	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 02/2002
51	Carcinogenesis 01/2017 - 09/2002
41	Liver Cirrhosis (Hepatic Cirrhosis) 10/2019 - 09/2003
30	Inflammation (Inflammations) 01/2017 - 11/2004
22	Obesity 03/2016 - 07/2006
19	Pancreatic Neoplasms (Pancreatic Cancer) 08/2019 - 01/2009
19	Colonic Neoplasms (Colon Cancer) 08/2018 - 01/2005
17	Liver Diseases (Liver Disease) 01/2019 - 01/2002
16	Fibrosis (Cirrhosis) 05/2018 - 07/2005
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 09/2017 - 06/2005
14	Body Weight (Weight, Body) 05/2015 - 01/2005
13	Colorectal Neoplasms (Colorectal Cancer) 07/2014 - 01/2004
11	Liver Neoplasms (Liver Cancer) 01/2018 - 07/2006
11	Malnutrition (Nutritional Deficiencies) 07/2014 - 01/2004
10	Hepatitis 03/2016 - 11/2002
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2015 - 06/2002
10	Insulin Resistance 01/2015 - 05/2009
9	Lymphoma (Lymphomas) 10/2018 - 11/2002
9	Infections 03/2016 - 01/2006
7	Ascites 01/2019 - 12/2011
7	Neoplasm Metastasis (Metastasis) 01/2018 - 03/2011
7	Adenoma (Adenomas) 03/2016 - 09/2002
6	Hypoalbuminemia 05/2018 - 04/2004
6	Hepatic Encephalopathy 05/2018 - 05/2010
6	Aberrant Crypt Foci 12/2014 - 09/2008
6	Leukemia 07/2013 - 05/2004
6	Chronic Hepatitis C 03/2013 - 12/2005
5	Hepatitis C 07/2016 - 01/2006
5	Non-alcoholic Fatty Liver Disease 05/2016 - 10/2011
5	Liver Failure 07/2014 - 01/2002
5	Carcinoma (Carcinomatosis) 08/2013 - 06/2003
5	Ulcer 11/2012 - 01/2002
4	Fatty Liver 01/2017 - 01/2011
4	Diabetes Mellitus 03/2016 - 07/2006
4	Adenocarcinoma 02/2016 - 09/2002
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016 - 08/2007

Drug/Important Bio-Agent (IBA)

39	Proteins (Proteins, Gene)FDA Link 08/2019 - 09/2002
26	3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA 01/2018 - 05/2002
21	Branched-Chain Amino AcidsIBA 05/2018 - 09/2003
17	Prednisolone (Predate)FDA LinkGeneric 12/2017 - 01/2002
17	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 01/2002
16	TeaIBA 03/2015 - 01/2005
15	Serum AlbuminIBA 10/2019 - 01/2004
15	Green Fluorescent ProteinsIBA 10/2018 - 01/2012
14	Red Fluorescent ProteinIBA 08/2019 - 01/2012
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 06/2002
13	Vincristine (Oncovin)FDA LinkGeneric 12/2017 - 06/2002
13	RetinoidsIBA 01/2014 - 11/2002
12	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 05/2016 - 08/2004
12	Pharmaceutical PreparationsIBA 03/2016 - 01/2009
12	InterferonsIBA 03/2013 - 05/2004
12	ErbB Receptors (EGF Receptor)IBA 12/2011 - 04/2005
11	Rituximab (Mabthera)FDA Link 09/2017 - 10/2006
11	Messenger RNA (mRNA)IBA 03/2016 - 05/2002
11	Retinoid X Receptors (Retinoid X Receptor)IBA 01/2014 - 02/2002
10	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 02/2004
10	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2016 - 02/2009
10	Phosphotransferases (Kinase)IBA 03/2015 - 01/2004
10	CytokinesIBA 08/2014 - 01/2002
9	AdipokinesIBA 03/2016 - 07/2010
9	AzoxymethaneIBA 02/2016 - 09/2002
8	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 09/2012 - 04/2005
7	KynurenineIBA 12/2017 - 04/2010
7	Drinking WaterIBA 02/2016 - 06/2004
7	tyrosine receptor (receptor, tyrosine)IBA 03/2015 - 06/2008
7	Epidermal Growth Factor (EGF)IBA 07/2011 - 04/2005
6	pirarubicinIBA 12/2017 - 02/2004
6	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2014 - 03/2005
6	LigandsIBA 10/2012 - 02/2002
6	Insulin-Like PeptidesIBA 03/2011 - 04/2008
6	beta CateninIBA 07/2010 - 09/2002
6	Retinoid X Receptor alphaIBA 11/2009 - 02/2002
5	Amino Acids FDA Link 12/2017 - 01/2004
5	Etoposide (VP 16)FDA LinkGeneric 09/2017 - 06/2002
5	Ribavirin (Virazole)FDA LinkGeneric 07/2016 - 12/2005
5	AlbuminsIBA 07/2016 - 04/2004
5	Gemcitabine FDA Link 03/2016 - 01/2009
5	Antineoplastic Agents (Antineoplastics)IBA 03/2016 - 05/2004
5	Tryptophan (L-Tryptophan)FDA Link 01/2016 - 10/2011
5	Insulin (Novolin)FDA Link 01/2015 - 09/2005
5	CateninsIBA 12/2014 - 06/2011
5	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2012 - 02/2002
5	AntigensIBA 01/2010 - 06/2005
5	Vitamin A (Retinol)FDA LinkGeneric 03/2009 - 04/2004
5	NF-kappa B (NF-kB)IBA 06/2008 - 11/2004
4	DiureticsIBA 05/2018 - 05/2014
4	Cyclin D1IBA 03/2016 - 03/2010
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 02/2016 - 03/2010
4	Dextrans (Dextran)FDA Link 02/2016 - 03/2010
4	EnzymesIBA 01/2016 - 05/2011

Therapy/Procedure

50	Therapeutics 01/2018 - 06/2002
39	Chemoprevention 03/2016 - 04/2004
22	Drug Therapy (Chemotherapy) 01/2018 - 06/2002
6	Intraperitoneal Injections 01/2016 - 08/2004
6	Subcutaneous Injections 05/2015 - 07/2010
5	Cell Transplantation 12/2017 - 11/2008
5	VAP-cyclo protocol 01/2014 - 11/2002
5	Aftercare (After-Treatment) 03/2013 - 09/2002
5	Oral Administration 09/2010 - 08/2002